Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bassem I Yamout

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Seminars in Neurology|May 24, 2018
Multiple SclerosisBassem I Yamout, Raed Alroughani
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 25, 2020
Treatment of multiple sclerosis in special populations: The case of refugeesMaya M Zeineddine, Bassem I Yamout
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 28, 2017
Letter to the editorBassem I Yamout, Maya M Zeineddine
Multiple Sclerosis and Related Disorders|October 14, 2019
Skin warts during fingolimod treatment in patients with multiple sclerosisNesreen Jaafar, Maya Zeineddine, Joelle Massouh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 11, 2017
Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorderBassem I Yamout, Shawkat Beaini, Maya M Zeineddine, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 18, 2023
Disease-modifying therapies enter the World Health Organization Essential Medicines List: A victory now requiring a roadmap of implementationBassem I Yamout, Shanthi Viswanathan, Joanna Laurson-Doube, et al.
Journal of Neuroimmunology|December 1, 2015
Safety and efficacy of fingolimod in clinical practice: The experience of an academic center in the Middle EastBassem I Yamout, Maya M Zeineddine, Hani Tamim, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 28, 2020
Epidemiology and phenotypes of multiple sclerosis in the Middle East North Africa (MENA) regionBassem I Yamout, Wassim Assaad, Hani Tamim, et al.
Journal of Neuroimmunology|July 23, 2015
Safety and efficacy of reduced fingolimod dosage treatmentBassem I Yamout, Maya M Zeineddine, Raja A Sawaya, et al.
Journal of the Neurological Sciences|September 6, 2017
Rebound syndrome after teriflunomide cessation in a patient with multiple sclerosisBassem I Yamout, Marianne Said, Salem Hannoun, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Seminars in Neurology|May 24, 2018
Multiple SclerosisBassem I Yamout, Raed Alroughani
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 25, 2020
Treatment of multiple sclerosis in special populations: The case of refugeesMaya M Zeineddine, Bassem I Yamout
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 28, 2017
Letter to the editorBassem I Yamout, Maya M Zeineddine
Multiple Sclerosis and Related Disorders|October 14, 2019
Skin warts during fingolimod treatment in patients with multiple sclerosisNesreen Jaafar, Maya Zeineddine, Joelle Massouh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 11, 2017
Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorderBassem I Yamout, Shawkat Beaini, Maya M Zeineddine, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 18, 2023
Disease-modifying therapies enter the World Health Organization Essential Medicines List: A victory now requiring a roadmap of implementationBassem I Yamout, Shanthi Viswanathan, Joanna Laurson-Doube, et al.
Journal of Neuroimmunology|December 1, 2015
Safety and efficacy of fingolimod in clinical practice: The experience of an academic center in the Middle EastBassem I Yamout, Maya M Zeineddine, Hani Tamim, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 28, 2020
Epidemiology and phenotypes of multiple sclerosis in the Middle East North Africa (MENA) regionBassem I Yamout, Wassim Assaad, Hani Tamim, et al.
Journal of Neuroimmunology|July 23, 2015
Safety and efficacy of reduced fingolimod dosage treatmentBassem I Yamout, Maya M Zeineddine, Raja A Sawaya, et al.
Journal of the Neurological Sciences|September 6, 2017
Rebound syndrome after teriflunomide cessation in a patient with multiple sclerosisBassem I Yamout, Marianne Said, Salem Hannoun, et al.
Pageof 4